ATTENDANCE ONLY – NO CME CREDIT
Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09
Meeting ID: 958 6138 0114
Passcode: 188969
Epilepsy
Elaine, Wirrell, M.D.
"Improving outcome in Persons with Developmental and Epileptic Encephalopathies (DEEs)"
Learning objectives:
Upon conclusion of this activity, participants will be able to:
- Differentiate developmental encephalopathy from epileptic encephalopathy
- Define appropriate therapeutic goals for persons with DEE
- Utilize etiology and syndrome to select the optimal therapy
Dr. Wirrell has the following relevant financial relationships to disclose Consulting: Consultant - GRIN Therapeutics; lama Therapeutics; Knopp Biosciences LLC; Abbott Laboratories; Acadia Pharmaceuticals, Inc.; Aquestive Therapeutics; Beacon Biomedical, Inc.; BioHaven Pharmaceuticals; BioMarin Pharmaceuticals, Inc.; Clinical Outcomes Solutions; Eisai, Inc.; Encoded Therapeutics; Initiate consultancy; Jazz Pharmaceuticals; Locanabio; Miller Medical Communications, LLC.; Neurocrine Biosciences, Inc.; Roche Laboratories, Inc.; Syneos Health; Taysha Gene Therapies; UCB, Inc.; Watermark Research Partners, LLC; Zogenix does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
There will be no credit for this session, however attendance will be marked for this session and will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.